Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Estudio fase 3, aleatorizado, doble ciego, controlado con placebo, basado en eventos para investigar el efecto de retatrutida sobre la incidencia de acontecimientos cardiovasculares adversos graves y el deterioro de la función renal en participantes con un índice de masa corporal =27 kg/m2 y enfermedad cardiovascular aterosclerótica y/o enfermedad renal crónica

  • Protocol code: J1I-MC-GZBO
  • EudraCT code: No aplica
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Ciudin Mihai, Andreea
  • Research group:  Diabetis i metabolisme
  • Service: Endocrinologia
  • Phase: Fase III
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Un estudio de fase 1, abierto y de un solo grupo para determinar la seguridad, la tolerabilidad y la eficacia preliminar de Obecabtagene Autoleucel en pacientes con lupus eritematoso sistémico grave y refractario

  • Protocol code: AUTO1-SL1
  • EudraCT code: No aplica
  • Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified
  • Principal investigator:  Cortes Hernandez, Josefina
  • Research group:  Reumatologia
  • Service: Reumatologia
  • Phase: Fase I
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de fase III, multicéntrico, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para evaLuar la efIcacia y la seguridad de abeLacimab en pacientes de alto riesgo con fibrilación Auricular que no se consideren adecuados para la antiCoagulación oral

  • Protocol code: ANT-010
  • EudraCT code: No aplica
  • Pathology: Tumors
  • Principal investigator:  Olivera Sumire, Pável Eduardo
  • Service: Hematologia i Hematoteràpia
  • Phase: Phase III
  • Recruiting: Closed
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A randomized, double-blind, placebo-controlled, parallelgroup,Proof-of-Concept (PoC) study to assess theefficacy,safety and tolerability of itepekimab in participants with non-cystic fibrosis bronchiectasis

  • Protocol code: ACT18018
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema respiratori
  • Principal investigator:  Polverino , Eva
  • Research group:  Pneumologia
  • Service: Pneumologia
  • Phase: Phase I
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Professionals

Erika Zodda

Professionals

Hanaa Boudoukhan Benriyyan

Psicòloga al Programa Psiquiatria Transcultural, especialitzada en intervenció en salut mental amb persones procedents de diferents orígens i cultura. Treballo amb persones que han patit situacions traumàtiques, amb manifestació del Trastorn per Estrès Postraumàtic, així com grups d'alta vulnerabili

Professionals

Julieta Torchia

Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Research Technician position Ophthalmology_
Codi
2024-197
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Bioinformatician Neurodegenerative Diseases Group_20240195
Codi
2024-195
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Psychologist Researcher-Psychiatry, Mental Health and Addictions Research Group_20240194
Codi
2024-194
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Clinical associated researcher-Research Area of Infectious Diseases_20240193
Codi
2024-193
Reclutant
Inactiu
Year
2024
Títol Complet
Suministro y puesta en servicio de un equipo de patología digital (Slide Scanner) para el Grupo de Oncologia Molecular en el Marco del IR-HUVH y gestionado por la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR).
Expedient
SUMINISTRO DE UN EQUIPO DE PATOLOGIA DIGITAL (IFEQ
Codi
24971329
Data publicació
Year
2024
Títol Complet
Contractació per al servei d'assessorament legal en matèria de Protecció de Dades i Propietat Intel·lectual, destinat al Grup de Recerca en Càncer i Malalties Hematològiques Infantils, línia d'investigació en anèmies rares, de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR).
Expedient
ASSESSORAMENT LOPD I PI
Codi
24971291
Data publicació
Year
2024
Títol Complet
Contractació d’un proveïdor pels servei per a la contractació de campanyes de captació de fons per al 2025 (face - to - face), i destinat a la Unitat de Mecenatge de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR)
Expedient
CAMPANYES FUNDRAISING
Codi
24971256
Data publicació
Year
2024
Títol Complet
Servicio de análisis de DNA para el Poryecto PMP22/00189 destinado al Grupo de Investigación en Cefalea de la Fundació Hospital Universitari Vall d’Hebron - Institut de Recerca (VHIR)
Expedient
SERVICIO DE ANÁLISIS DE DNA (PMP22/00189)
Codi
24971255
Data publicació